BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Sientra to Release Third Quarter 2017 Financial Results

  Sientra will hold a conference call on Tuesday, November 7, 2017 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results.

  November 3, 2017

   · 

  3 min read
• Business

  AIT Therapeutics Reports Third Quarter 2017 Financial Results

  The Company had cash and cash equivalents of $3.8 million at September 30, 2017, compared to $5.2 million at June 30, 2017.

  November 3, 2017

   · 

  15 min read
• NeuroVive Conducts a Directed New Share Issue of SEK 5.3M

  Proceeds from the new share issue will be used primarily for continued clinical development of KL1333 and NeuroSTAT.

  November 3, 2017

   · 

  3 min read
• Drug Development

  Alexion Release: New Interim Data Presented at NASPGHAN 2017 Meeting Show Survival Beyond 1 Year of Age in Infants With LAL-D Treated With Kanuma (Sebelipase Alfa)

  Survival: the Kaplan-Meier estimate of survival to 12 months of age was 90 percent.

  November 3, 2017

   · 

  10 min read
• Genetown

  Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) On Nov. 1

  The granted option has an exercise price of $61.83 per share, which is equal to the closing price of Sage’s common stock on November 1, 2017.

  November 3, 2017

   · 

  2 min read
• Business

  New License Agreement Sets Course for Development of Cancer Drugs With Targeting Ability

  The license agreement grants the spin-out company ADCendo worldwide rights to explore and commercialize certain inventions made by researchers at the Finsen Laboratory related to ADC drugs targeting the novel uPARAP receptor.

  November 3, 2017

   · 

  6 min read
• 

  FDA

  Medacta Wins FDA Nod and First Surgeries Utilizing 3DMetal Tibial Cones for Knee Revision

  The 3DMetal Tibial Cones can be used for structural support in areas of bone deficiencies that may compromise revision implant fixation.

  November 3, 2017

   · 

  3 min read
• Biotech Beach

  BIOLASE Announces Terms of Rights Offering

  Upon commencement of the rights offering on November 8, 2017, the Company will distribute to its shareholders as of 5:00 p.m., Eastern Time, on November 8, 2017.

  November 3, 2017

   · 

  4 min read
• Biotech Beach

  ReShape Lifesciences Presents New Data on Obesity Technologies

  The presentation discussed 342 patients that were implanted with the ReShape Integrated Dual Balloon at a multicenter bariatric practice.

  November 3, 2017

   · 

  6 min read
• Biotech Beach

  PharmaCyte Biotech Releases Shareholder Call Playback Information

  PharmaCyte Biotechannounced today that an audio recording of the company’s shareholder call, which was held on November 1, 2017, by the Chief Executive Officer of PharmaCyte, Kenneth L. Waggoner, is now available for playback.

  November 3, 2017

   · 

  3 min read